New ventilator is specifically designed for the clinical requirements of non-invasive therapy of acute respiratory failure and respiratory therapy.
The first clinical studies of non-invasive ventilation in intensive care relied on systems from sleep apnea therapy or home ventilation, which had proven successful for use with masks. Because of the special circumstances of home care, these were turbine driven devices with a single hose that were typically equipped with a passive expiration valve in the form of a stricture. The special requirements for non-invasive ventilation in acute medicine developed over time, based on the increasing establishment of NIV therapy, new scientific insights, practical experiences and technological advances. A wide range of studies and publications focused on trigger safety, CO2 elimination, reliable leakage compensation, and pressure-controlled ventilation patterns with volume specifications.
The new ventilator by SALVIA, which is specifically designed for the clinical requirements of non-invasive ventilation and respiratory therapy, marks a departure from the previous technologies of home ventilation. The new NI 60 ventilator offers a solution that is as modern as it is technologically effective. Its highly responsive measuring and control technology, comprehensive leakage compensation, and trigger detection based on adaptive byflow technology make no compromise in ventilation therapy in spite of mask-related leakages. NIV has to quickly and flexibly respond to all changes in order to make the most of its strengths for the patient's benefit. However, leakage rates during mask ventilation are subject to continuous variation, which hampers spontaneous breathing at the upper pressure level and CO2 elimination. It may also impede the reliable detection of the trigger signal and the criterion for activating pressure support. The NI 60 system continuously measures, displays, and adjusts mask-related leakage. Furthermore, the display provides precise data about the leakage status. Because of the active valve control of expiration, the device can rely on high-speed control algorithms as well as innovative ventilation formats with volume specification, which prevents the risk of rebreathing CO2. NI 60 is designed for non-invasive ventilation in cases of acute respiratory failure with nose/mouth mask, full-face masks, or ventilation helmets as well as for clinical respiratory therapy.